Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methylene blue and Alzheimer's disease
Murat Öz, Dietrich E. Lorke, Georg Petroianu
Biochemical Pharmacology (2009) Vol. 78, Iss. 8, pp. 927-932
Closed Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Cellular and molecular actions of Methylene Blue in the nervous system
Murat Öz, Dietrich E. Lorke, Mohammed Y. Hasan, et al.
Medicinal Research Reviews (2009) Vol. 31, Iss. 1, pp. 93-117
Open Access | Times Cited: 391
“Lest we forget you — methylene blue …”
R. Heiner Schirmer, Heike Adler, Marcus Pickhardt, et al.
Neurobiology of Aging (2011) Vol. 32, Iss. 12, pp. 2325.e7-2325.e16
Closed Access | Times Cited: 385
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
Salvatore Salomone, Filippo Caraci, Gian Marco Leggio, et al.
British Journal of Clinical Pharmacology (2011) Vol. 73, Iss. 4, pp. 504-517
Open Access | Times Cited: 293
The Revitalized Tau Hypothesis on Alzheimer's Disease
Ricardo B. Maccioni, Gonzalo Farías, Inelia Morales, et al.
Archives of Medical Research (2010) Vol. 41, Iss. 3, pp. 226-231
Closed Access | Times Cited: 281
A novel green synthesis of silver nanoparticles and their catalytic action in reduction of Methylene Blue dye
Jayanta Saha, A. Adeela Begum, Avik Mukherjee, et al.
Sustainable Environment Research (2017) Vol. 27, Iss. 5, pp. 245-250
Open Access | Times Cited: 259
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review
Bárbara D. Fontana, Nathana J. Mezzomo, Allan V. Kalueff, et al.
Experimental Neurology (2017) Vol. 299, pp. 157-171
Closed Access | Times Cited: 221
Self‐Powered Iontophoretic Transdermal Drug Delivery System Driven and Regulated by Biomechanical Motions
Changsheng Wu, Peng Jiang, Wei Li, et al.
Advanced Functional Materials (2019) Vol. 30, Iss. 3
Closed Access | Times Cited: 146
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Nathan Herrmann, Sarah Chau, Ida Kircanski, et al.
Drugs (2011) Vol. 71, Iss. 15, pp. 2031-2065
Closed Access | Times Cited: 223
Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
John C. O’Leary, Qingyou Li, Paul S. Marinec, et al.
Molecular Neurodegeneration (2010) Vol. 5, Iss. 1
Open Access | Times Cited: 178
Methylene blue: revisited.
Prashant R Ginimuge, S. D. Jyothi
PubMed (2010)
Open Access | Times Cited: 166
CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
P. Ken Gillman
Journal of Psychopharmacology (2010) Vol. 25, Iss. 3, pp. 429-436
Closed Access | Times Cited: 165
Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue
Julio C. Rojas, Aleksandra K. Bruchey, F. Gonzalez‐Lima
Progress in Neurobiology (2011) Vol. 96, Iss. 1, pp. 32-45
Open Access | Times Cited: 161
Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase
Hani Atamna, Raj Kumar
Journal of Alzheimer s Disease (2010) Vol. 20, Iss. s2, pp. S439-S452
Open Access | Times Cited: 131
Strategies for the Inhibition of Protein Aggregation in Human Diseases
Manuela Bartolini, Vincenza Andrisano
ChemBioChem (2010) Vol. 11, Iss. 8, pp. 1018-1035
Closed Access | Times Cited: 130
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
Katja Hochgräfe, Astrid Sydow, Dorthe Matenia, et al.
Acta Neuropathologica Communications (2015) Vol. 3, Iss. 1
Open Access | Times Cited: 122
Oxidative Toxicity in Neurodegenerative Diseases: Role of Mitochondrial Dysfunction and Therapeutic Strategies
Katie Facecchia, Lee-Anne Fochesato, Sidhartha D. Ray, et al.
Journal of Toxicology (2011) Vol. 2011, pp. 1-12
Open Access | Times Cited: 114
Mitochondrial respiration as a target for neuroprotection and cognitive enhancement
F. Gonzalez‐Lima, Bryan Barksdale, Julio C. Rojas
Biochemical Pharmacology (2013) Vol. 88, Iss. 4, pp. 584-593
Closed Access | Times Cited: 102
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
María del Carmen Cárdenas‐Aguayo, Laura Gómez-Virgilio, Steven DeRosa, et al.
ACS Chemical Neuroscience (2014) Vol. 5, Iss. 12, pp. 1178-1191
Closed Access | Times Cited: 100
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review
Guangyu Lu, M. Nagbanshi, N. Goldau, et al.
BMC Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 96
Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2018) Vol. 158, pp. 359-375
Closed Access | Times Cited: 95
Insights into Disease-Associated Tau Impact on Mitochondria
Leonora Szabo, Anne Eckert, Amandine Grimm
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6344-6344
Open Access | Times Cited: 72
Ultrasensitive SERS substrates based on Au nanoparticles photo-decorated on Cu2O microspheres for the detection of rhodamine B and methylene blue
Elumalai Ashok Kumar, Tzyy- Jiann Wang, Yu‐Hsu Chang
Applied Surface Science (2022) Vol. 585, pp. 152696-152696
Closed Access | Times Cited: 55
Biosynthesis of silver and gold nanoparticles using Sargassum horneri extract as catalyst for industrial dye degradation
Woo Chang Song, Beomjin Kim, Sun Young Park, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 9, pp. 104056-104056
Open Access | Times Cited: 47
Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system
Mohammad Umar, Yasir Rehman, Subiya Ambreen, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102298-102298
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top